Skip to main navigation

Contact Us

Investor Relations

Our Company
Product Candidates
- Pipeline
- MultiTAA Therapies
Our Science
Clinical Trials
- Active Clinical Trials
- Expanded Access Policy
Investors/Media
Careers

Investors/Media

Press Releases

Press Releases

Year

Jan 15, 2019

The Center for Cell and Gene Therapy at Baylor College of Medicine to Present at the Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR 2019

Jan 03, 2019

Marker Therapeutics Provides Updates of its Lead Clinical Programs

Dec 06, 2018

Marker Therapeutics to Present at the Tumor Targeted Lymphocytes Summit

Nov 27, 2018

The Center for Cell and Gene Therapy at Baylor College of Medicine to Present at the 60th American Society of Hematology Annual Meeting

Nov 27, 2018

Marker Therapeutics, Inc. Appoints Anthony H. Kim as Chief Financial Officer

Nov 08, 2018

Marker Therapeutics to Present at Three Upcoming Healthcare Conferences

Oct 23, 2018

Marker Therapeutics, Inc. Announces New Executive Appointments

Oct 18, 2018

Marker to Present at Two Upcoming Cellular Therapy Conferences

Oct 17, 2018

TapImmune And Marker Therapeutics Announce Successful Closing Of Previously Announced Merger And Financing

Pagination

First page
Previous page
…
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Page 10
Current page 11

Displaying 101 - 109 of 109

Investors/Media

Investors/Media Home
News & Events
- Press Releases
- Events & Presentations
Stock Information
Financials & Filings
Corporate Governance
Investor Resources

IR and Media Contacts

investor.relations@markertherapeutics.com
(713) 400-6400

©2024 Marker Therapeutics, Inc. All Rights Reserved.

Footer Links

Sitemap
Terms of Use
Privacy Policy